(Q34557669)

3 August 2017

title

The AST/ALT ratio as an indicator of cirrhosis in patients with PBC. (English)

1 reference

3 August 2017

0 references

Sven Almer

5

0 references

Magnus Simrén

3

object named as

Magnus Simrén

1 reference

3 August 2017

Helena Nyblom

1

1 reference

3 August 2017

Einar Björnsson

2

1 reference

3 August 2017

Frank Aldenborg

4

1 reference

3 August 2017

Rolf Olsson

6

1 reference

3 August 2017

publication date

1 September 2006

1 reference

3 August 2017

1 reference

3 August 2017

volume

26

1 reference

3 August 2017

issue

7

1 reference

3 August 2017

page(s)

840-845

1 reference

Management of hepatocellular carcinoma

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01304.X

Ursodeoxycholic acid and histological progression in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01304.X

The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01304.X

Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01304.X

Outcome of patients hospitalized for complications after outpatient liver biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01304.X

High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01304.X

Progressive liver functional impairment is associated with an increase in AST/ALT ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01304.X

Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01304.X

AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01304.X

Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01304.X

The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01304.X

AST/ALT ratio > or = 1 is not diagnostic of cirrhosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01304.X

Aspartate aminotransferase-immunoglobulin complexes in patients with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01304.X

Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01304.X

Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01304.X

Alcoholic liver disease: a clinical series in an Australian private practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01304.X

10.1111/J.1478-3231.2006.01304.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference